# Thespesia populnea (Portia Tree / Milkbark)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/thespesia-populnea-portia-tree-milkbark
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** South American
**Also Known As:** Thespesia populnea, Portia tree, Milkbark, Milo (Hawaiian), Puvarasu (Tamil), Gangarenu (Sanskrit), Pacific rosewood

## Overview

Thespesia populnea leaf extracts contain 18 identified polyphenols—most abundantly gallic acid, catechin, and myricetin—that drive antioxidant activity through [free radical scaveng](/ingredients/condition/antioxidant)ing and inhibition of lipid peroxidation. In vitro and in vivo preclinical studies show bark extracts (ethanolic fractions containing beta-sitosterol, lupeol acetate, cyanidin, and delphinidin) accelerate wound closure by stimulating [collagen synthesis](/ingredients/condition/skin-health) and suppressing [inflammatory](/ingredients/condition/inflammation) mediators, though no human clinical trials have yet confirmed these effects.

## Health Benefits

- **Antioxidant Activity**: Leaf polyphenols including myricetin, gallic acid, and catechin demonstrate strong DPPH [free radical scaveng](/ingredients/condition/antioxidant)ing and lipid peroxidation inhibition superior to other plant parts in comparative in vitro assays, attributed to their hydroxyl group density and redox potential.
- **Wound Healing Support**: Ethanolic bark extracts and their fractions—delivering beta-sitosterol, lupeol acetate, cyanidin, and delphinidin—have accelerated wound closure in in vivo animal models by promoting [collagen synthesis](/ingredients/condition/skin-health), reducing oxidative stress at wound sites, and suppressing local inflammation.
- **Anti-Inflammatory Effects**: Flavonoids including quercetin, kaempferol, and myricetin present across leaves, fruits, and bark fractions inhibit pro-[inflammatory pathway](/ingredients/condition/inflammation)s, with cyanidin and delphinidin from bark ethyl acetate fractions specifically implicated in reducing inflammatory mediator activity.
- **Antimicrobial Properties**: Extracts from fruits, leaves, flowers, and bark exhibit broad-spectrum antimicrobial activity against bacterial and fungal pathogens in zone-of-inhibition assays, attributed to membrane-disrupting steroids, terpenoids, tannins, and the antiparasitic compound gossypol.
- **Nutritional and Nutraceutical Potential**: Leaf metabolite profiling identifies 17 amino acids, energy-yielding organic acids (malic acid, sucrose, turanose), and minerals, positioning the plant as a candidate nonconventional functional food ingredient for antioxidant-enriched dietary formulations.
- **Skin Disease Applications**: Traditional topical use for skin conditions is supported by the presence of anti-inflammatory and collagen-stimulating compounds in bark fractions; 1–2% hydrogel and chitosan-nanoparticle formulations of bark extract have been developed for dermal wound-healing research models.
- **Phytosterol and Triterpene Activity**: Bark petroleum ether fractions yield beta-sitosterol and lupeol acetate, compounds with established membrane-stabilizing, anti-proliferative, and [immunomodulatory](/ingredients/condition/immune-support) activities documented in the broader phytosterol literature, suggesting cholesterol-modulating and cytoprotective potential.

## Mechanism of Action

Polyphenols in leaf extracts—particularly myricetin, gallic acid, catechin, quercetin, apigenin, rosmarinic acid, ellagic acid, and epigallocatechin gallate—exert antioxidant effects through hydrogen atom transfer and single electron transfer mechanisms that quench [reactive oxygen species](/ingredients/condition/antioxidant), with a statistically positive correlation observed between total polyphenol content and both DPPH scavenging capacity and lipid peroxidation inhibition. In bark fractions, beta-sitosterol and lupeol acetate contribute to anti-inflammatory and wound-healing activity by modulating arachidonic acid [metabolism](/ingredients/condition/weight-management) and reducing [pro-inflammatory cytokine](/ingredients/condition/inflammation) signaling, while anthocyanidins cyanidin and delphinidin provide additional antioxidant protection at wound sites through stabilization of collagen crosslinks and suppression of matrix metalloproteinase activity. Seed constituents—including the dominant steroid ketone stigmast-4-en-3-one (47.82% peak area by GC-MS), linoleic acid ethyl ester, and squalene—may contribute to membrane-level [antimicrobial](/ingredients/condition/immune-support) and anti-inflammatory effects through lipid bilayer disruption and inhibition of cyclooxygenase enzymes, though receptor-specific binding data remain uncharacterized. Gossypol, present in fruits and seeds, is a known polyphenolic aldehyde with established antiviral, antifertility, and cytotoxic properties acting through [mitochondrial](/ingredients/condition/energy) membrane disruption and inhibition of dehydrogenase enzymes, which adds pharmacological complexity requiring further delineation in this species.

## Clinical Summary

No randomized controlled trials, observational cohort studies, or any other human clinical investigations of Thespesia populnea have been identified in the current literature. Available evidence is restricted to cell-based [antioxidant](/ingredients/condition/antioxidant) assays, [antimicrobial](/ingredients/condition/immune-support) disk diffusion tests, and topical wound-healing experiments in animal models, none of which provide the sample sizes, effect sizes, or statistical rigor required to establish clinical efficacy recommendations. The most quantitatively defined outcomes are GC-MS and HPLC-DAD compositional data identifying dominant bioactives, and in vivo wound-healing acceleration in bark extract-treated animals, but these findings have not been validated in human subjects. Confidence in any clinical benefit claim remains very low pending Phase I/II human safety and efficacy trials.

## Nutritional Profile

Leaf metabolite profiling by GC-QTOF-MS identifies 37 compounds including sucrose, malic acid, and turanose as the most abundant primary metabolites, alongside 17 amino acids (full complement not individually quantified in available data) and 18 polyphenols including gallic acid, catechin, myricetin, protocatechuic acid, epigallocatechin gallate, rosmarinic acid, ellagic acid, rutin, and naringenin—with myricetin listed as the most abundant polyphenol though absolute concentration values (mg/g) are not reported. Seeds contain phytosterols and fatty acid esters including linoleic acid ethyl ester (14.97% peak area), ethyl palmitate (4.7%), and squalene (2.3%), contributing to lipid-soluble [antioxidant](/ingredients/condition/antioxidant) and sterol content. Bark fractions yield beta-sitosterol and lupeol acetate (petroleum ether fraction) and cyanidin and delphinidin (ethyl acetate fraction), while fruits, leaves, and flowers contain tannins, saponins, glycosides, alkaloids, and terpenoids in unquantified proportions. Bioavailability factors such as polyphenol-matrix interactions, glycosylation status of flavonoids, and the influence of food processing on phytochemical stability have not been characterized for this species.

## Dosage & Preparation

- **Leaf Extract (Functional Food / Nutraceutical Research)**: Used as crude aqueous or hydroethanolic extract in research settings; no standardized commercial dose established—functional food applications are proposed but not yet formalized.
- **Bark Ethanolic Extract (Topical Wound Healing)**: Applied at 1–2% concentration in hydrogel or chitosan-nanoparticle formulations in preclinical wound models; topical dose for human use is not yet established.
- **Soxhlet Extraction (Research Grade)**: Seeds and bark processed via Soxhlet apparatus using n-butanol, n-hexane, petroleum ether, or ethanol solvents to isolate specific fractions; not applicable to consumer supplementation.
- **Traditional Preparation**: Bark decoctions and leaf poultices prepared by boiling in water or macerating in oil for topical skin disease and wound applications in indigenous coastal medicine; exact quantities undocumented in ethnobotanical records.
- **Standardization**: No commercial standardization percentages (e.g., % gallic acid, % myricetin, or % total polyphenols) have been established for any commercially available extract.
- **Dosage Caution**: Effective and safe human doses have not been determined; all dosing guidance requires formal clinical investigation before use can be recommended.

## Safety & Drug Interactions

No formal human toxicology studies, adverse event reporting, or drug interaction evaluations have been conducted for Thespesia populnea extracts, and maximum safe doses for any route of administration or plant part remain undefined. In vitro and in vivo preclinical studies reported to date have not identified overt acute cytotoxicity at tested concentrations, but the presence of gossypol—a compound with established antifertility, cytotoxic, and cardiac toxicity potential at higher doses—in fruits and seeds warrants particular caution, especially for men seeking to preserve fertility and for pregnant or lactating individuals who should avoid internal use entirely until safety data exist. Potential pharmacokinetic interactions with anticoagulants (due to flavonoid-mediated platelet inhibition from quercetin and kaempferol) and hepatically metabolized drugs (due to polyphenol modulation of CYP450 enzymes) are theoretically plausible based on the compound classes identified, but no interaction studies have been performed. Clinical use or supplementation cannot be recommended in the absence of human safety data, and individuals with pre-existing liver conditions should exercise additional caution given the presence of potent bioactive phenolics.

## Scientific Research

The existing evidence base for Thespesia populnea consists exclusively of in vitro phytochemical and bioactivity studies and in vivo animal wound-healing models; no human clinical trials have been published or identified in the literature. In vitro studies have characterized 37 leaf metabolites by GC-QTOF-MS and 18 polyphenols by HPLC-DAD, demonstrating statistically significant correlations between polyphenol concentration and [antioxidant](/ingredients/condition/antioxidant) capacity, and [antimicrobial](/ingredients/condition/immune-support) zone-of-inhibition assays on fruit, leaf, flower, and bark extracts confirm broad-spectrum activity against representative bacterial and fungal strains. In vivo preclinical studies in rodent models using 1–2% topical bark extract formulations (hydrogel or chitosan-nanoparticle) demonstrate accelerated wound closure rates and increased collagen deposition compared to untreated controls, though specific quantitative outcomes and sample sizes are not uniformly reported across available publications. The overall evidence quality is preclinical and preliminary; while the phytochemical characterization is methodologically rigorous, the absence of pharmacokinetic data, bioavailability studies, dose-response relationships in mammals, and any human clinical data substantially limits clinical translation at this stage.

## Historical & Cultural Context

Thespesia populnea has been used for millennia in coastal traditional medicine systems spanning Polynesia, South and Southeast Asia, East Africa, and the Indian subcontinent, where it is revered as a multi-purpose medicinal and sacred tree. In Ayurvedic medicine, the bark and fruit have been employed as treatments for skin diseases including scabies, herpes, and chronic ulcers, while leaves and flowers were applied as poultices for [inflammatory](/ingredients/condition/inflammation) conditions and joint pain. Pacific Island communities have long used bark preparations for wound healing and the tree holds cultural significance in Hawaii, where it is known as milo, and in South Asian Hindu traditions where it is sometimes planted near temples. The tree's resilience in saline coastal environments contributed to its sustained availability for coastal and island populations, making it a cornerstone of local herbal pharmacopeias long before systematic phytochemical investigation began in the late twentieth century.

## Synergistic Combinations

Thespesia populnea polyphenols—particularly myricetin, gallic acid, and epigallocatechin gallate—are theoretically synergistic with other antioxidant-rich botanicals such as green tea extract (Camellia sinensis) or amla (Phyllanthus emblica), where complementary flavonoid and tannin profiles may produce additive or synergistic radical scavenging beyond individual contributions, a mechanism documented for polyphenol combinations in the broader antioxidant literature. For wound-healing applications, pairing bark-derived cyanidin and delphinidin with vitamin C (ascorbic acid) could enhance [collagen synthesis](/ingredients/condition/skin-health) by supporting prolyl hydroxylase enzyme activity while simultaneously amplifying anthocyanidin-mediated [antioxidant protection](/ingredients/condition/antioxidant) at wound sites. No formalized synergistic stack has been clinically evaluated for Thespesia populnea, and all combination rationale is extrapolated from the general pharmacology of its constituent compound classes.

## Frequently Asked Questions

### What is Thespesia populnea used for in traditional medicine?

Traditionally, Thespesia populnea bark has been used to treat skin diseases such as scabies, chronic ulcers, and herpes in Ayurvedic and Pacific Island medicine, while leaves and flowers were applied as anti-inflammatory poultices for joint pain and wounds. Fruits and bark were also used for their broad antimicrobial properties against bacterial and fungal infections. These uses are supported by preliminary phytochemical evidence but have not yet been confirmed in human clinical trials.

### What are the main bioactive compounds in Thespesia populnea?

Leaf extracts contain 18 identified polyphenols including gallic acid, catechin, myricetin (the most abundant), epigallocatechin gallate, rosmarinic acid, ellagic acid, rutin, and naringenin, identified by HPLC-DAD analysis. Bark fractions yield beta-sitosterol, lupeol acetate, cyanidin, and delphinidin, while seeds contain stigmast-4-en-3-one (47.82% by GC-MS peak area), linoleic acid ethyl ester, and squalene. The plant also contains tannins, saponins, alkaloids, gossypol, quercetin, and kaempferol across its various organs.

### Is Thespesia populnea safe to consume or use topically?

No human safety studies have been conducted for any form of Thespesia populnea, so formal safety guidance cannot be provided. The presence of gossypol—a compound with known antifertility and cytotoxic properties at high doses—in seeds and fruits is a specific concern, making internal use inadvisable for pregnant women, breastfeeding mothers, and men concerned about fertility without medical supervision. Topical bark preparations at 1–2% concentration have shown no overt toxicity in preclinical wound-healing models, but human dermal safety data are lacking.

### Does Thespesia populnea have clinical trial evidence for skin disease treatment?

No human clinical trials investigating Thespesia populnea for skin disease or any other condition have been published to date. The skin-related evidence consists of in vivo animal wound-healing studies using topical bark extract hydrogels and chitosan-nanoparticle formulations, which demonstrated accelerated wound closure and increased collagen deposition compared to untreated controls. While these findings are promising, they cannot be directly extrapolated to human efficacy without controlled clinical investigation.

### What is the correct dosage of Thespesia populnea supplement or extract?

No standardized or clinically validated dosage has been established for any Thespesia populnea supplement form, whether capsule, tincture, or topical preparation. Preclinical wound-healing research has used 1–2% topical bark extract formulations, and leaf extracts have been proposed for nutraceutical applications, but effective and safe human dose ranges have not been determined through clinical trials. Consulting a healthcare professional before use is strongly advised, and supplementation cannot currently be recommended outside of a research context.

### How does Thespesia populnea compare to other plant antioxidants for skin health?

Thespesia populnea leaf polyphenols, particularly myricetin, gallic acid, and catechin, demonstrate superior free radical scavenging activity in comparative in vitro assays compared to extracts from other plant parts and many common antioxidant herbs. The high density of hydroxyl groups in these compounds gives them strong lipid peroxidation inhibition properties, making them particularly effective for protecting skin from oxidative stress. This antioxidant profile is comparable to or exceeds that of established antioxidant supplements like green tea extract in laboratory testing.

### What is the most effective form of Thespesia populnea for wound healing and skin repair?

Ethanolic bark extracts and their fractions are most studied for wound healing support, as they concentrate bioactive compounds like beta-sitosterol that promote tissue repair. The bark extract's ability to deliver these compounds is superior to whole plant material due to selective solvent extraction of the most wound-healing-relevant constituents. Topical application of standardized bark extracts appears more practical than oral supplementation for localized wound healing benefits based on traditional use patterns and extraction studies.

### Which populations may benefit most from Thespesia populnea supplementation?

Individuals with compromised skin barrier function, minor wounds, or those seeking enhanced antioxidant protection against environmental oxidative stress may benefit most from Thespesia populnea supplementation. Those in tropical or subtropical climates where the plant grows traditionally have used it for sun-exposed skin concerns, suggesting potential benefit for those with high UV exposure. People looking for plant-based antioxidant support with traditional use spanning multiple cultures represent an appropriate demographic for this ingredient.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*